Eva Glud
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
-
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Risks and Factors
Papers in
-
- Ovarian cancer diagnosis and treatment 5
- Oncology 5
- Peptidase Inhibition and Analysis 2
- Cancer-related Molecular Pathways 1
- Cancer Risks and Factors 1
- HER2/EGFR in Cancer Research 1
- Co-authors
- Susanne K. Kjær (14 shared papers)Claus Kim Høgdall (13 shared papers)Jan Blaakær (13 shared papers)Estrid Vilma Solyom Høgdall (13 shared papers)Lise Hanne Christensen (10 shared papers)Johannes E. Bock (9 shared papers)Kirsten Frederiksen (3 shared papers)Birthe Lykke Thomsen (1 shared paper)
- Journals
- Cancer Causes & Control (2 papers)Gynecologic Oncology (2 papers)Cancer (2 papers)Epidemiologic Reviews (1 paper)Apmis (1 paper)
- Partner nations
- DenmarkUnited KingdomUnited States
In The Last Decade
Eva Glud
15 papers receiving 572 citations
Peers
Comparison fields: 5 of 51
- Reproductive Medicine 242
- Oncology 178
- Obstetrics and Gynecology 45
- Cancer Research 77
- Immunology 56
Countries citing papers authored by Eva Glud
This map shows the geographic impact of Eva Glud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Glud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Glud more than expected).
Fields of papers citing papers by Eva Glud
This network shows the impact of papers produced by Eva Glud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Glud. The network helps show where Eva Glud may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Glud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 120 | |
| 2 | 2004 | 100 | |
| 3 | 2003 | 77 | |
| 4 | 2006 | 49 | |
| 5 | 2006 | 43 | |
| 6 | 1998 | 38 | |
| 7 | The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients. | 2004 | 32 |
| 8 | Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients. | 2002 | 29 |
| 9 | 2002 | 25 | |
| 10 | 2013 | 23 | |
| 11 | 2003 | 21 | |
| 12 | 2004 | 16 | |
| 13 | 2005 | 14 | |
| 14 | Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study. | 2003 | 11 |
| 15 | [P-pills and risk of breast cancer. A review of studies published 1970-1990]. | 1992 | 1 |
About Eva Glud
Eva Glud is a scholar working on Reproductive Medicine, Oncology, Immunology and Allergy, Obstetrics and Gynecology and Cancer Research, having authored 15 papers that have together received 599 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (5 papers), Peptidase Inhibition and Analysis (2 papers), Studies on Chitinases and Chitosanases (1 paper), Protease and Inhibitor Mechanisms (1 paper), Cell Adhesion Molecules Research (1 paper), Cancer-related Molecular Pathways (1 paper), Cancer Risks and Factors (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Reproductive Medicine (242 citations), Oncology (178 citations), Obstetrics and Gynecology (45 citations), Cancer Research (77 citations) and Immunology (56 citations). Eva Glud has collaborated with scholars based in Denmark, United Kingdom and United States. Frequent co-authors include Susanne K. Kjær, Claus Kim Høgdall, Jan Blaakær, Estrid Vilma Solyom Høgdall, Lise Hanne Christensen, Johannes E. Bock, Kirsten Frederiksen, Birthe Lykke Thomsen, Louise Annette Brinton and Jens Vuust. Their work appears in journals such as Cancer Causes & Control, Gynecologic Oncology, Cancer, Epidemiologic Reviews and Apmis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.